Type something and hit enter

ads here
Home invest in investing living frugal what to invest in Non-Profit progressing with positive PII/III trials for very low-cost HCV cure. Potential long-term impacts to $GILD and $ABBV.

Non-Profit progressing with positive PII/III trials for very low-cost HCV cure. Potential long-term impacts to $GILD and $ABBV.

On
advertise here

https://www.theguardian.com/science/2018/apr/12/non-profits-300-hepatitis-c-cure-as-effective-as-84000-alternative

Potential to erode profits from both Gilead and Abbvie in their Hep. C franchises.



Submitted April 12, 2018 at 08:18AM by EasyE0287 https://ift.tt/2HyH8DO
invest ininvestingliving frugalwhat to invest in
advertise here

Click to comment
Subscribe to: Post Comments (Atom)